ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 57 filers reported holding ONCOCYTE CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,000 | -98.1% | 573 | -98.4% | 0.00% | – |
Q1 2022 | $54,000 | -30.8% | 36,073 | 0.0% | 0.00% | – |
Q4 2021 | $78,000 | -39.5% | 36,073 | -0.4% | 0.00% | – |
Q3 2021 | $129,000 | -53.8% | 36,212 | -25.6% | 0.00% | – |
Q2 2021 | $279,000 | +11.6% | 48,693 | +1.2% | 0.00% | – |
Q1 2021 | $250,000 | +166.0% | 48,100 | +22.1% | 0.00% | – |
Q4 2020 | $94,000 | +70.9% | 39,400 | 0.0% | 0.00% | – |
Q3 2020 | $55,000 | -26.7% | 39,400 | 0.0% | 0.00% | – |
Q2 2020 | $75,000 | +200.0% | 39,400 | +294.0% | 0.00% | – |
Q1 2020 | $25,000 | +8.7% | 10,000 | 0.0% | 0.00% | – |
Q4 2019 | $23,000 | +9.5% | 10,000 | 0.0% | 0.00% | – |
Q3 2019 | $21,000 | -79.0% | 10,000 | -75.0% | 0.00% | – |
Q2 2019 | $100,000 | +203.0% | 40,000 | +154.8% | 0.00% | – |
Q1 2018 | $33,000 | -54.8% | 15,700 | 0.0% | 0.00% | – |
Q4 2017 | $73,000 | -38.7% | 15,700 | 0.0% | 0.00% | – |
Q3 2017 | $119,000 | +45.1% | 15,700 | 0.0% | 0.00% | – |
Q2 2017 | $82,000 | +30.2% | 15,700 | +15.7% | 0.00% | – |
Q1 2016 | $63,000 | – | 13,574 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 3,596,680 | $27,155,000 | 4.50% |
Family Management Corp | 20,550 | $155,000 | 0.11% |
Artal Group S.A. | 150,000 | $1,133,000 | 0.02% |
Destination Wealth Management | 29,656 | $224,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 145,000 | $1,095,000 | 0.01% |
Carroll Financial Associates, Inc. | 850 | $5,000 | 0.00% |
Advisor Group, Inc. | 112 | $1,000 | 0.00% |
FIFTH THIRD BANCORP | 210 | $2,000 | 0.00% |
HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
AMERICAN INTERNATIONAL GROUP, INC. | 2,413 | $18,000 | 0.00% |